T cell responses remain broadly robust against Omicron variant of SARS-CoV-2

A team of international scientists has recently conducted a mutational analysis of key T cell epitopes of the omicron variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The findings reveal that T cell responses remain significantly strong against the variant.

Study: SARS-CoV-2 T cell responses are expected to remain robust against Omicron. Image Credit: Naeblys/ShutterstockStudy: SARS-CoV-2 T cell responses are expected to remain robust against Omicron. Image Credit: Naeblys/Shutterstock

The study is currently available on the bioRxiv* preprint server, while the article undergoes peer review.


The most recently emerged SARS-CoV-2 variant of concern (VOC) is the omicron variant, which was first detected in South Africa in November 2021. The whole-genome sequencing analysis has suggested that the variant contains several mutations in the key spike epitopes, indicating improved immune fitness. Preliminary studies conducted in real-world pandemic situations have indicated that the variant might potentially escape humoral immune responses induced by infection or vaccination. However, it is still unclear whether the variant is capable of escaping cellular immune responses mediated by T cells.

T cells are vital components of the adaptive immune system. Besides eliminating infected cells, T cells actively participate in activating B cells for antibody production. Robust T cell responses induced by SARS-CoV-2 infection or vaccination have been found to increase viral clearance and reduce disease severity, despite low antibody responses.

In the current study, the scientists have investigated whether omicron mutations affect spike-specific T cell responses induced by infection or vaccination. They have considered all spike-specific CD8+ and CD4+ T cell epitopes of SARS-CoV-2 and screened them against omicron-specific mutations.

Important observations

The mutational analysis revealed that about 14% of CD8+ T cell epitopes and 28% of CD4+ T cell epitopes contain at least one residue related to an omicron mutation. This finding indicates that most of the T cell epitopes remain unaffected by omicron mutations.

The human leukocyte antigen (HLA) system encodes cell surface molecules that are responsible for presenting antigenic peptide to T cells for viral recognition. In the study, computational modeling was conducted to predict the effects of omicron mutations on the interaction between spike-specific T cell epitopes and their cognate HLA alleles.

The findings revealed that seven CD8+ and 12 CD4+ epitopes were lost due to deletion mutations in the omicron spike protein. Similarly, the mutations caused loss of binding to sixCD8+ and 4 CD4+ epitopes. These observations indicate that most of the T cell epitopes containing omicron mutations retain HLA binding and that there is less possibility of T cell escape.

Non-spike specific T cell responses

The analysis of non-spike specific T cell responses is particularly important as natural infection and inactivated coronavirus disease 2019 (COVID-19) vaccines are known to target T cell epitopes derived from multiple SARS-CoV-2 proteins besides spike protein. In the study, the analysis of all non-spike T cell epitopes revealed that the majority of them are unaffected by omicron mutations. Overall, the mutations caused putative loss of four nucleocapsid-specific T cell epitopes.

Immunodominant T cell epitopes

The analysis of 20 most commonly targeted T cell epitopes (immunodominant epitopes) revealed that omicron mutations are not present in any of these epitopes. Since multiple epitopes are commonly targeted within an individual, these findings suggest that the overall T cell response against the omicron variant remain largely unaffected by mutations.

Study significance

The study findings reveal that the majority of T cell epitopes targeted in vaccinated or previously infected individuals remain unaffected by omicron mutations. Thus, it can be expected that pre-existing T cell immunity will have a robust impact against the newly emerged omicron variant.

Overall, the study highlights the significance of robust T cell responses in preventing severe omicron infections, despite increased infectivity and antibody escape ability of the variant.

*Important notice

bioRxiv publishes preliminary scientific reports that are not peer-reviewed and, therefore, should not be regarded as conclusive, guide clinical practice/health-related behavior, or treated as established information.

Journal reference:
Dr. Sanchari Sinha Dutta

Written by

Dr. Sanchari Sinha Dutta

Dr. Sanchari Sinha Dutta is a science communicator who believes in spreading the power of science in every corner of the world. She has a Bachelor of Science (B.Sc.) degree and a Master's of Science (M.Sc.) in biology and human physiology. Following her Master's degree, Sanchari went on to study a Ph.D. in human physiology. She has authored more than 10 original research articles, all of which have been published in world renowned international journals.


Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Dutta, Sanchari Sinha. (2021, December 16). T cell responses remain broadly robust against Omicron variant of SARS-CoV-2. News-Medical. Retrieved on May 18, 2022 from https://www.news-medical.net/news/20211216/T-cell-responses-remain-broadly-robust-against-Omicron-variant-of-SARS-CoV-2.aspx.

  • MLA

    Dutta, Sanchari Sinha. "T cell responses remain broadly robust against Omicron variant of SARS-CoV-2". News-Medical. 18 May 2022. <https://www.news-medical.net/news/20211216/T-cell-responses-remain-broadly-robust-against-Omicron-variant-of-SARS-CoV-2.aspx>.

  • Chicago

    Dutta, Sanchari Sinha. "T cell responses remain broadly robust against Omicron variant of SARS-CoV-2". News-Medical. https://www.news-medical.net/news/20211216/T-cell-responses-remain-broadly-robust-against-Omicron-variant-of-SARS-CoV-2.aspx. (accessed May 18, 2022).

  • Harvard

    Dutta, Sanchari Sinha. 2021. T cell responses remain broadly robust against Omicron variant of SARS-CoV-2. News-Medical, viewed 18 May 2022, https://www.news-medical.net/news/20211216/T-cell-responses-remain-broadly-robust-against-Omicron-variant-of-SARS-CoV-2.aspx.


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
You might also like...
The longitudinal progression of health outcomes in COVID-19 survivors with different initial disease severity